A series of novel Pd(II) complexes with chelating mono(imidazolin-2-imine) and bis(imidazolin-2-imine) 
Palladium(II) complexes with highly basic imidazolin-2-imines and their reactivity toward small bio-molecules † . The substitution of the chloride ligands in these complexes by TU, L-Met, L-His and Gly was studied under pseudo-first-order conditions as a function of the nucleophile concentration and temperature using stopped-flow techniques; the sulfur-donor nucleophiles have shown better reactivity than nitrogen-donor nucleophiles. 
Introduction
The chemical behavior, in solution, of structurally analogous Pt(II) and Pd(II) complexes is very similar, which has advanced the progress of research in the area of the development of new Pd(II) complexes. 1 However, palladium(II) complexes react ca. 10 4 -10 5 times faster than their platinum(II)
analogues, 1 so the selectivity of such complexes in the binding of bio-molecules is limited, which leads to low anti-tumor activity. The reaction rate of Pd(II) complexes can be slowed down and side reactions can be prevented through the introduction of inert sterically hindered ligands into the coordination sphere of the complex. A common practice in anticancer drug development is to modify leading structures in a suitable way that maximizes cytotoxic potency toward cancer cells. [2] [3] [4] Nowadays, cisplatin and its analogues are among the most effective chemotherapeutic agents in clinical use for the treatment of different types of cancers. [2] [3] [4] [5] However, the advantages and drawbacks of the widely used platinum-based anticancer drug cisplatin prompted a search for analogous transition 3, 4, 6 To overcome the disadvantages of cisplatin, a huge number of metal ion complexes, among which are the Pd(II) complexes, were synthesized and tested. [7] [8] [9] The chemistry of imidazolin-2-imine ligands has attracted attention because of the characteristic ability of imidazolines for effective acquisition and stabilization of a positive charge, which leads to the pronounced basic properties of nitrogen donor atoms and the formation of highly stable nitrogenmetal bonds. 10 These features make imidazolin-2-imines the ideal ancillary ligands for applications in homogeneous catalysis. Over the past 10 years, this has led to the synthesis and application of a significant number of their metal complexes (from main group elements to lanthanides and actinides) in coordination chemistry and homogeneous catalysis. [10] [11] [12] We anticipated that the great electron donating capacity and bulkiness of the mono-and bis(imidazolin-2-imine) ligands would result in Pd(II) complexes with greatly reduced reactivity; these complexes should in turn have increased potential as anti-tumor agents. Fig. 1 shows the structures of the Pd(II) complexes used in this study.
Results and discussion

Ligand synthesis
The ligands were synthesized in analogy to the procedure described in a previous publication. 13 Stirring one equivalent of 2-chloro-1,3-diisopropyl-4,5-dimethylimidazolium salt, six equivalents of KF, three equivalents of triethylamine and an appropriate amount of different amines in acetonitrile overnight at room temperature gave the desired ligand salts (Scheme 1). 
Complex synthesis
The complexes shown in Fig. 1 Fig. 2 . The molecule crystallizes in the orthorhombic space group Pnma, with one co-crystallized molecule of CH 2 Cl 2 per asymmetric unit and one located on a crystallographic mirror plane. The ligand is coordinated to the palladium atom in a chelating, bidentate fashion with an N1-Pd-N2 bite angle of 83.08(9)°. The Pd-N bond lengths are 2.013(2) and 2.076(2) Å for Pd-N1 and Pd-N2, respectively, indicating a stronger coordination of the more basic imine nitrogen to the Pd atom.
The imine bond length of 1.349(4) Å (N1-C3) is long for a CvN double bond, indicating a pronounced negative charge on the imine nitrogen. This is also confirmed by the ρ-value of 0.998; the ρ-value is defined as ρ = 2a/(b + c), with (a) denoting the exo-and (b) and (c) the endo-cyclic bond lengths within the guanidine CN 3 moiety. Values approaching unity indicate complete charge delocalization within the CN 3 fragment. 15 The electron-donating capacity of the imidazolin-2-imine is also reflected in the different Pd-Cl bond lengths, with the Pd-Cl1 bond length (2.3390(7) Å) trans to the imine nitrogen being significantly longer than the Pd-Cl2 bond length (2.2951 (7) molecule of hexane per asymmetric unit. The ligand is coordinated to the palladium atom in a chelating, bidentate fashion with an N1-Pd-N2 bite angle of 82.69(14)°. The Pd-N bond lengths are virtually identical at 2.034(4) and 2.038(3) Å for Pd-N1 and Pd-N2, respectively. The imine C15-N1 bond length of 1.367(5) Å is long for a CvN double bond and the corresponding ρ-value of 1.004 indicates a strong negative charge on the exocyclic imine nitrogen atom. Again, the PdCl2 (2.3395(10) Å) distance trans to the imine nitrogen is longer than the Pd-Cl bond which is trans to the primary amine Pd-Cl1 (2.3193(10) Å).
Solubility of the imidazolin-2-imine Pd(II) complexes
Despite the fact that the prepared Pd(II) complexes are neutral, UV-Vis spectrophotometric measurements showed that they have good solubility in water (see Table 1 ). The solubility of the complexes is about four times greater than that observed for cisplatin and ca. twice that of oxaliplatin. This high solubility is promising for the intended application of these complexes as anti-tumor agents. To this day, cisplatin is the most widely used metal complex based cytostatic in the world. [2] [3] [4] [5] One of the drawbacks of cisplatin as an anti-tumor drug is its low solubility in aqueous media, therefore an increase in water solubility is an important goal in the design of any new metallo-drug. A higher water solubility can also result in a decreased toxicity of metallo-drugs, as is the case for oxaliplatin, which has less nephrotoxicity and a higher water solubility than cisplatin. There is a correlation between the pK a values of the coordinated water molecules and the electronic structure of the complexes and accordingly the reactivity of the complexes. Therefore, the pK a values of the complexes in aqueous solution were determined. This was done via UV-vis spectrophotometric pH titration with NaOH as a base in the pH range between 2 and 12. Each pK a titration was performed twice and the average of both values was taken. Fig. 4 (see also Fig. S2-S4 of the ESI †) shows a plot of the absorbance versus pH at specific wavelengths, which was used to determine the pK a values of the coordinated water molecules. The data were fitted using a nonlinear least-squares procedure, as shown in the inset of Fig. 4 . The overall process can be presented by eqn (1) and (2) . The data obtained for the pK a values are summarized in Table 2 . viz. an imidazolin-2-imine moiety and an sp 3 -hybridized primary or tertiary amine (-NR 2 ) unit. In these cases, it can be assumed that the first aqua ligand to be deprotonated would be that trans to the less electron donating amine donor. The pH in healthy human cells lies between 7.3 and 7.4.
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As the pK a1 values listed in Table 2 are lower than 7.3, the formation of Pd(II) monohydroxo species can be expected. Conver- species while other complexes will exist as monohydroxo species. Formation of monohydroxo species and diaqua complexes is good because Pd-OH species are more substitutioninert but Pd-OH can also act as a base, deprotonating a H-N site in nucleobases and binding to the N atom, while diaqua species can readily bind to DNA.
Kinetic studies
To get an idea of the robustness of the Pd(II) complexes in living tissue, the substitution reactions of Pd(II) complexes with selected nucleophiles (Fig. 5 ) was investigated. The change in absorbance was followed, at suitable wavelengths, as a function of time at 310 K and pH ≈ 7.2. The proposed reaction pathways for all the observed substitution processes are presented in Scheme 2. The substitution reactions of all Pd(II) complexes proceed in two successive reaction steps that are both dependent on the nucleophile concentration. The entering ligands, L-Met, L-His and Gly, are essential amino acids; therefore, the metal complex (as an antitumor active drug) on its way from the injection to the diseased tissue will encounter them. On the basis of many investigations in the field of Pt(II) and Pd(II) complexes, it is known that both ions can easily form a bond with thioethers (such as L-Met). 1, 14, 17 Pt-sulfur(thioether) adducts have been postulated to be a drug reservoir for platinum and may act as intermedi- ate platinum complexes that can be transformed into Pt-DNA adducts, 17 which makes the study of substitution reactions with L-Met very important. Thiourea was selected because it is a ligand with high solubility, neutral character and good nucleophilicity. Also, thiourea combines the ligand properties of thiolates as π donors 21 and thioethers as σ donors and π acceptors. 22 Also, thiourea is used as a protective and rescue agent to prevent side effects which are caused by Pt(II) antitumor drugs. 23, 24 Therefore, the investigation of the interactions of the selected nucleophiles and Pd(II) complexes is important for the development of potential antitumor drugs. The substitution reactions of square-planar metal complexes can proceed according to two parallel pathways. 25 One involves the formation of a solvent-coordinated complex, e.g. a diaqua complex, followed by rapid substitution of the coordinated solvent by the entering nucleophile (solvolytic pathway), whilst the other involves a direct nucleophilic attack by the entering nucleophile. To suppress the solvolytic pathway, a 30 mM NaCl solution was added (see the ESI, Fig. S5 †) . The rate constants for substitution could be determined, under pseudo-first-order conditions, from a plot of the linear dependence of k obsd versus the total nucleophile concentration, according to eqn (3) and (4) . The slope of the line represents k 1 or k 2 , whilst the intercept represents
. Plots of k obsd1,2 versus nucleophile concentration led to a linear dependence with no meaningful intercept for all complexes and both substitution steps. The results are summarized in Tables 3 and 4 . including the necessary time scales for both reaction steps are shown in Fig. 6 . The order of reactivity of the investigated Pd(II) complexes for both reaction steps is (Table 3) : would take place next to the less sterically hindered side of the ligand viz. next to the amine donor. Therefore, the next substitution would have to take place next to the bulky imidazolin-2-imine donor, rendering it less facile. In addition, the first substitution would result in a less electrophilic Pd(II) center, reducing the reaction rate for the second substitution. Interestingly, the rate constants which were obtained for the substitution reactions of the studied imidazolin-2-imine Pd(II) complexes are in line with the rate constants determined for substitution reactions of aqua Pt(II) complexes (Table S1 , ESI †). 26 This confirms that the investigated complexes have decreased reactivity, since it is known that Pd(II) complexes react much faster than Pt(II) complexes. 1 The low reactivity of the investigated complexes raises the possibility that they might find biological application. The rate constants, k 1 , presented in Table 3 , indicate that the used nitrogen and sulfur donor ligands are good entering ligands in the substitution reactions with the investigated Pd(II) complexes.
The order of reactivity of the investigated nucleophiles for the first reaction step is: TU > L-Met > L-His > Gly, Table 3 . This is the expected order of reactivity, as sulfur-donor nucleophiles react faster with Pd(II) complexes than nitrogen-donor nucleophiles. The Pd(II) ion is a soft acid and will easily form bonds with a soft base such as sulfur.
The data for the second substitution step show that TU reacts faster than L-His. Kinetic traces for reactions with L-Met and Gly gave fits with a double exponential function. The constants, k obsd1 and k obsd2 , were plotted against the concentration of the entering L-Met or Gly nucleophiles. For k obsd1 , a linear dependence on the nucleophile concentration was observed for all the complexes studied; k obsd2 was found to be independent of the L-Met or Gly concentration, suggesting a chelate formation process as presented in Scheme 3 and Fig. 8 .
The substitution reactions of the investigated Pd(II) complexes with L-Met proceed with a nucleophilic attack by the sulfur donor of the thioether group, and subsequently a sixmembered ring (see Scheme 3) is formed by substitution with the nitrogen donor of the amine group. The acid dissociation constants of free L-Met are: pK COOH = 2.28, 27 pK NH 3+ = 9.2, 27 so ring-closure must involve deprotonation of the amine group (Scheme 3). Ring-closure and formation of a six-membered ring also occur in the substitution reactions of Pt(II) complexes and L-Met. 17, 28 In the substitution reaction between Gly and the investigated Pd(II) complexes, the formation of a five-membered ring is confirmed. The nucleophilic attack occurs via the nitrogen donor of the amine group and then via the oxygen from the carboxyl group (Scheme 3). A similar ring-closure between Pd(II) or Pt(II) complexes and Gly was observed in earlier publications. 28, 29 To confirm that the second step is chelation, the kinetics were studied with the Pd(II) complexes in excess instead of L-Met or Gly. This would mean that a two-step reaction can only occur if ring closure is involved. The obtained kinetic traces for such reactions gave fits to a double exponential function. Similar values for the rate constants were obtained compared to those observed in the experiments with L-Met or Gly added in excess (see the ESI Fig. S13 and 14 †) . All this indicates that ring closure occurs. for the first substitution step, the right graph presents absorbance-time traces for both substitution steps at pH 7.2 and 310 K in 25 mM Hepes buffer and 30 mM NaCl.
Scheme 3 The second step of the substitution reaction of the investigated Pd(II) complexes with L-Met and Gly.
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Activation parameters
The activation parameters ΔH ≠ and ΔS ≠ (Table S2 †) were calculated using the Eyring equation for the reactions with TU (see Fig. 9 and S12, ESI †) for the first and second reaction steps. The activation parameters support an associative mechanism for each of these reactions which is supported by the significantly negative activation entropies. This suggests that the activation process in the studied systems is strongly dominated by bond formation.
Conclusion
In conclusion, we were able to use novel imidazolin-2-imine ligands for the synthesis of a series of new Pd(II) complexes. The coordination of imidazolin-2-imine ligands to Pd(II) gives three benefits with regard to the utilization of such complexes as metallo-drugs. The first is an increase of the solubility of these Pd(II) complexes, as the low solubility of neutral Pd(II) and Pt(II) complexes, such as cisplatin, is one of the major disadvantages in their application as cytostatics. Secondly, imidazolin-2-imine Pd(II) complexes react more slowly than most of the known Pd(II) complexes; their reactivity is such that it lies in the same range as that of aqua Pt(II) complexes. The reduced reactivity of Pd(II) complexes should lead to a better selectivity of such complexes in the binding of biomolecules. Lastly, the introduction of imidazolin-2-imines leads to an increase of the pK a values of the coordinated water molecules in these complexes. For assumed that they will exist mostly as diaqua species at the pH of tumor cells. These combined advantages should lead to a more selective attack of these complexes at the DNA of tumor cells as a final target in drug delivery.
Experimental
Chemicals and solutions
Thiourea, L-methionine, L-histidine, glycine, ethylenediamine,
Bu and PdCl 2 were obtained from Acros Organics or Sigma Aldrich, and were used without further purification. Hepes buffer (N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid) was obtained from Sigma Aldrich. All the other chemicals were of the highest purity commercially available and were used without further purification. Ultra-pure water was used in all experiments. Nucleophile stock solutions were prepared shortly before use by dissolving the chemicals.
Preparation of the ligands and complexes
All reactions were performed in a glove box under a dry argon atmosphere (MBraun 200B) or on a high-vacuum line using standard Schlenk techniques, unless noted otherwise. Commercial grade solvents were purified by the use of a solvent purification system from MBraun GmbH and stored over molecular sieves (4 Å) under a dry argon atmosphere.
All the syntheses of the ligands started from 2-chloro-1,3-diisopropyl-4,5-dimethylimidazolium tetrafluoroborate, which was prepared according to a literature procedure. Bu at 0°C. The mixture was stirred and allowed to warm to room temperature, and it was subsequently stirred overnight. The THF was removed in vacuo. The residue was extracted twice with 50 mL of pentane and filtered through celite. The solvent was removed in vacuo. The product was obtained as a light brown oil (6.15 g, 23.1 mmol, 91% . To a mixture of 1.50 g (4.95 mmol; 1 eq.) of 2-chloro-1,3-diisopropyl-4,5-dimethylimidazolium tetrafluoroborate and 1.74 g (29.9 mmol; 6 eq.) of KF in 15 mL of CH 3 CN was added 1.5 mL (22.2 mmol; 4.4 eq.) of ethylenediamine. The mixture was stirred overnight at room temperature. After filtration, in air, through celite and subsequent washing with 20 mL of CHCl 3 the organic fraction was washed with a dilute NaBF 4 solution (2.7 g; 24.6 mmol NaBF 4 in 100 mL of water). The organic layer was dried over Na 2 SO 4 , after which the solvent was removed in vacuo. This gave the product as a yellow oil (1.39 g, 4.26 mmol, 86% Synthesis and characterization of [EAIm iPr ] (4) by deprotonation of (3). To a solution of 1.54 g (4.7 mmol; 1 eq.) of 3 in 21 mL of THF was added 0.64 g (5.7 mmol; 1.2 eq.) of KO t Bu.
The reaction mixture was stirred for several days at room temperature. The solvent was removed in vacuo and the residue was extracted three times with 15 mL of pentane. The pentane was subsequently removed in vacuo to yield the product as an orange oil (0.87 g, 3.6 mmol, 77% (5). To a solution of 1.5 g (3.1 mmol; 1 eq.) of 5 in 20 mL of THF was added 0.146 g (3.7 mmol; 1.2 eq.) of NaNH 2 . The reaction mixture was stirred overnight at 40°C. The solvent was removed in vacuo and the residue was extracted three times with 15 mL of pentane. The pentane was subsequently removed in vacuo to yield the product as a yellow oil (0.92 g, 2.4 mmol, 75% 0.41 mmu).
Preparation of aqua complexes
The aqua complexes of Pd(II) complexes were prepared starting from the corresponding chlorido complexes. The conversion was performed by the addition of the corresponding amount of AgClO 4 to a solution of the chloride complex and stirring for 5 h at 50°C. The white precipitate that formed (AgCl) was filtered off using a Millipore filtration unit, and the solutions were diluted. Great care was taken to ensure that the resulting solution was free of Ag + ions and that the chlorido complexes had been completely converted into the aqua form. Since it is well known that perchlorate ions do not coordinate to Pd(II) and Pt(II) in aqueous solution, 33 pH titrations were studied in perchlorate medium.
Instrumentation and measurements
NMR spectra were recorded on Bruker DPX 200, DRX 400 and AV 300 devices. Chemicals shifts (δ) are reported in ppm and referenced to tetramethylsilane ( 1 H, 13 C) and trichlorofluoromethane ( 19 F). Coupling constants ( J) are reported in hertz (Hz) and splitting patterns are indicated as s (singlet), d (doublet), t (triplet), sept (septet), bs (broad signal) and m (multiplet). Elemental analyses (C, H, N) were performed by combustion and gas chromatographic analysis with an Elementar Vario MICRO elemental analyzer. High resolution electron spray ionization (ESI) mass spectroscopy was performed on a Finnigan MAT 95 XL trap device. pH measurements were carried out using a Mettler Delta 350 digital pH meter with a resolution of ±0.01 mV, with a combination glass electrode. This electrode was calibrated using standard buffer solutions of pH 4, 7 and 9 obtained from Sigma. Kinetic measurements of the Pd(II) complex were carried out on an Applied Photophysics SX.18MV stopped-flow instrument coupled to an online data acquisition system. The temperature was controlled throughout all kinetic experiments to ±0.1°C. All kinetic measurements were performed under pseudo-first-order conditions, i.e., at least a 10-fold excess of the nucleophile was used. UV-Vis spectra were recorded on a PerkinElmer Lambda 35 double-beam spectrophotometer equipped with thermostated 1.00 cm quartz Suprasil cells.
Determination of the pK a values of the Pd(II) complexes
Spectrophotometric pH titrations of the solutions of the complexes were performed with NaOH as a base at 298 K. To avoid absorbance corrections due to dilution, a large volume (300 mL) of the complex solution was used in the titration. The change in pH from 2 to approximately 3 was achieved by the addition of known amounts of crushed pellets of NaOH. The consecutive pH changes were obtained by adding drops of saturated solutions of NaOH, 1 or 0.1 M, using a micropipette. To avoid contamination released by the pH electrode, it was necessary to take 2 mL aliquots from the solution into narrow vials for the pH measurements. The aliquots were discarded after the measurements. The total reversibility of the titration could be achieved by subsequent addition of HClO 4 . The titration data for the complexes were fitted to the following eqn (5) for the determination of both pK a values [34] [35] [36] and the obtained data are presented in Table 2 .
The parameter a represents the value of the absorbance at the beginning of the titration, b represents the absorbance during the titration and c is the absorbance at the end of the titration. The parameters m and n are used to optimize the titration curve. In this equation y represents the absorbance value and x refers to the pH.
Solubility measurements
The concentrations of saturated solutions of the studied Pd(II) complexes were determined by UV-vis spectrophotometry. Therefore the specific absorptivity of the compounds in water was determined first. This was measured using five dilution series (5, 10, 30, 40, 50 mM) of the studied complexes and then the calibration curve was calculated using the LambertBeer law. The slope of the curve gave specific absorptivity.
The required quantity of water solution was added to the 5 ml volumetric flask. The solution was heated up to 298 K. A previously weighed quantity of Pd(II) complexes was added to the volumetric flask until the saturation point occurs. Stirring was continued up to 7 hours at 298 K. The sample was filtered through a 0.20 μm membrane filter. A measured quantity of the filtered sample was transferred into another volumetric flask and made further dilutions. The absorbance was measured using UV-vis spectrophotometry. The same process was repeated two times.
Kinetic measurements
The substitution reactions of the Pd(II) complex with the nucleophiles: TU, L-Met, L-His and Gly were studied spectrophotometrically by following the change in absorbance at suitable wavelengths as a function of time. Spectral changes resulting from the mixing of the complex and nucleophile solutions were recorded over the wavelength range 200 to 400 nm to establish a suitable wavelength at which kinetic measurements could be performed. Substitution reactions were initiated by mixing equal volumes of the complex and ligand solutions directly in the stopped-flow instrument and followed for at least eight halflives. The substitution process was monitored as the change in absorbance with time under pseudo-first-order conditions. The observed pseudo-first-order rate constants, k obsd , were calculated as the average value from four to six independent kinetic runs using the program OriginPro 8. Experimental data are reported in Tables S3-S26 (ESI †).
X-ray diffraction studies
Data were recorded at 100(2) K using an Oxford Diffraction Nova A diffractometer with monochromated Cu Kα radiation. The structures were refined anisotropically using the SHELXL-97 program. 37 Gly Glycine
